Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥1,033 JPY
Change Today -12.00 / -1.15%
Volume 8.8K
As of 11:44 PM 07/5/15 All times are local (Market data is delayed by at least 15 minutes).

canbas co ltd (4575) Snapshot

Open
¥1,045
Previous Close
¥1,045
Day High
¥1,049
Day Low
¥1,033
52 Week High
01/14/15 - ¥2,959
52 Week Low
07/18/14 - ¥680.00
Market Cap
4.7B
Average Volume 10 Days
45.5K
EPS TTM
¥-73.72
Shares Outstanding
4.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CANBAS CO LTD (4575)

Related News

No related news articles were found.

canbas co ltd (4575) Related Businessweek News

No Related Businessweek News Found

canbas co ltd (4575) Details

CanBas Co., Ltd., a clinical-stage biopharmaceutical company, discovers and develops oncology drugs in Japan. The company’s lead product comprise CBP501, which has completed Phase II clinical trials for the treatment of late stage malignant pleural mesothelioma and non-small cell lung cancer; and has completed Phase I clinical trial for ovarian cancer. It also develops CBS9106 and CBS2400 preclinical stage products. The company was founded in 2000 and is based in Numazu, Japan.

12 Employees
Last Reported Date: 09/26/14
Founded in 2000

canbas co ltd (4575) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

canbas co ltd (4575) Key Developments

CanBas Co., Ltd. to Report Q3, 2015 Results on May 14, 2015

CanBas Co., Ltd. announced that they will report Q3, 2015 results on May 14, 2015

CanBas Co., Ltd. to Report Q2, 2015 Results on Feb 13, 2015

CanBas Co., Ltd. announced that they will report Q2, 2015 results on Feb 13, 2015

CanBas Co., Ltd. Presents at BIO-Europe Spring 2015, Mar-09-2015

CanBas Co., Ltd. Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4575:JP ¥1,033.00 JPY -12.00

4575 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4575.
View Industry Companies
 

Industry Analysis

4575

Industry Average

Valuation 4575 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 129.3x
Price/Book 4.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 103.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANBAS CO LTD, please visit www.canbas.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.